세계의 청신경종 시장 보고서(2025년)

Acoustic Neuroma Global Market Report 2025

US $ 4,490 ￦ 6,496,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,390,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,284,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

청신경종 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 예측기간의 주요 동향으로는 이환율 증가, 기술 혁신, 시장확대, 공동연구 이니셔티브, 치료방법의 진보 등을 들 수 있습니다.

건강 관리 분야에 대한 투자의 급증은 청신경종 시장의 성장을 이끌 것으로 예상됩니다. 및 시설을 포함합니다. 건강 관리에 대한 투자 증가는 수요 증가, 기술 혁신, 규제 변경, 세계 건강 문제 등 다양한 요인에 의해 추진되고 있습니다. 같은 질병에 대한 진단과 치료의 진보를 지원하고, 궁극적으로는 환자의 결과와 삶의 질을 향상시킵니다. 2022년 미국의 헬스케어 지출은 4.1% 증가하여 총액 4조 5,000억 달러에 이르렀고, 헬스케어 분야에 대한 투자 증가가 청신경종 시장 확대에 박차를 가했습니다.

청신경종 시장의 주요 기업은 혁신적인 치료법, 특히 청신경종 환자에 맞는 방사선 수술 방법의 개발에 주력하여 더욱 풍부한 기능과 이점을 제공합니다. 청신경종에 대한 방사선 수술 방법은 종양에 방사선을 정확하게 조사하고 주변 건강한 조직에 대한 손상을 최소화하면서 종양을 파괴하거나 감소시킵니다. 예를 들어 스웨덴에 본사를 두고 있는 의료기술기업인 일렉터는 뇌종양, 혈관기형, 기능장애를 표적으로 한 고정밀도의 정위방사선 수술용으로 설계된 선진적인 방사선수술 시스템인 일렉타 에스프리를 2022년 5월에 발표했습니다. Elekta Esprit은 임상의에게 신속한 자동 치료 계획을 제공하여 탁월한 정밀도로 보다 개별화된 환자 친화적인 치료를 가능하게 합니다. 이 첨단 시스템은 뛰어난 시각화, 원격 액세스 및 협업 도구를 제공하며, 치료 팀은 방사선 수술에 대한 부드럽고 개인화된 접근 방식을 보장하면서 가장 어려운 대상에도 탁월한 정확도로 대응할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 그리고 경기 회복이 시장에 미치는 영향을 포함한 거시 경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 청신경종 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 청신경종 시장 : 성장률 분석
• 세계의 청신경종 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 청신경종 시장 : 규모와 성장(2024-2029년, 2034년)
• 세계의 청신경종 전체 시장(TAM)

제6장 시장 세분화

• 세계의 청신경종 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 편측성 전정 신경초종
• 양측성 전정 신경초종
• 세계의 청신경종 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 약물
• 항경련제
• 방사선 치료
• 양성자 치료
• 정위적 방사선 수술
• 세계의 청신경종 시장 : 진단 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 자기 공명 영상(MRI)
• 컴퓨터 단층 촬영 스캔(CT 스캔)
• 청력 검사
• 세계의 청신경종 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원
• 클리닉
• 수술센터
• 세계의 청신경종 시장 : 편측성 전정 신경초종 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 작은 편측성 전정 신경초종
• 중간 편측성 전정 신경초종
• 큰 편측성 전정 신경초종
• 악성 편측성 전정 신경초종
• 기타 편측성 전정 신경초종
• 세계의 청신경종 시장 : 양측성 전정 신경초종 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 가족성 양측 전정 신경초종
• 산발성 양측 전정 신경초종
• 기타 양측성 전정 신경초종

제7장 지역별/국가별 분석

• 세계의 청신경종 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 청신경종 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 청신경종 시장 : 경쟁 구도
• 청신경종 시장 : 기업 프로파일
  • Pfizer Inc 개요, 제품 및 서비스, 전략 및 재무 분석
  • F. Hoffmann-La Roche AG 개요, 제품 및 서비스, 전략 및 재무 분석
  • General Electric Company 개요, 제품 및 서비스, 전략 및 재무 분석
  • Merck & Co. Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Sanofi SA 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• AstraZeneca plc
• Abbott Laboratories
• Novartis AG
• GSK plc
• Medtronic plc
• Canon Medical Systems Corporation
• Toshiba Medical Systems Corporation
• Amgen Inc.
• Siemens Healthineers
• Teva Pharmaceuticals Industries Ltd
• Olympus Corporation
• Shimadzu Corporation
• Varian Medical Systems
• Elekta AB
• Cochlear Limited

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 청신경종 시장(2029년) : 새로운 기회를 제공하는 국가
• 청신경종 시장(2029년) : 새로운 기회를 제공하는 부문
• 청신경종 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

KTH

영문 목차

영문목차

Acoustic neuroma, also known as vestibular schwannoma, is a benign tumor that develops on the vestibular nerve, linking the inner ear to the brain and responsible for transmitting balance and hearing information. These tumors typically progress slowly and remain confined to their original location, manifesting symptoms such as hearing loss, tinnitus (ringing in the ear), dizziness, imbalance, facial numbness or weakness, and coordination difficulties.

The primary types of acoustic neuroma include unilateral vestibular schwannomas and bilateral vestibular schwannomas. Unilateral vestibular schwannomas refer to tumors that develop on one side of the vestibulocochlear nerve, affecting both hearing and balance functions. Treatment options encompass medications, anticonvulsants, radiation therapy, proton therapy, and stereotactic radiosurgery. Diagnosis typically involves magnetic resonance imaging (MRI), computed tomography scan (CT-scan), and hearing tests. End users involved in the management of acoustic neuroma include hospitals, clinics, and surgical centers.

The acoustic neuroma market research report is one of a series of new reports from The Business Research Company that provides acoustic neuroma market statistics, including acoustic neuroma industry global market size, regional shares, competitors with a acoustic neuroma market share, detailed acoustic neuroma market segments, market trends and opportunities, and any further data you may need to thrive in the acoustic neuroma industry. This acoustic neuroma market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acoustic neuroma market size has grown strongly in recent years. It will grow from $1.83 billion in 2024 to $1.99 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to advancements in imaging technologies, surgical innovations, increased awareness and screening programs, economic factors, and regulatory approvals.

The acoustic neuroma market size is expected to see strong growth in the next few years. It will grow to $2.72 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to technological advancements, personalized medicine, rising healthcare spending, patient preferences and demands, and healthcare infrastructure development. Major trends in the forecast period include increasing incidence rates, technological innovations, market expansion, collaborative research initiatives, and advancements in treatment modalities.

The surge in investment in the healthcare sector is anticipated to drive the growth of the acoustic neuroma market. The healthcare sector encompasses a broad range of services and facilities aimed at promoting health, providing medical care, and improving overall well-being for individuals and populations. Increased investment in healthcare is driven by various factors, including rising demand, technological innovation, regulatory changes, and global health challenges. These investments support advancements in diagnostics and treatments for conditions such as acoustic neuroma, ultimately enhancing patient outcomes and quality of life. For example, data from the Centers for Medicare & Medicaid Services (CMS) in December 2023 indicated a 4.1% increase in healthcare spending in the U.S. in 2022, reaching a total of $4.5 trillion. Consequently, the growing investment in the healthcare sector is fueling the expansion of the acoustic neuroma market.

Key players in the acoustic neuroma market are focusing on developing innovative treatment options, particularly radiosurgery methods tailored for acoustic neuroma patients, to offer enhanced features and benefits. Radiosurgery methods for acoustic neuroma involve precisely delivering radiation to the tumor to destroy or shrink it while minimizing damage to surrounding healthy tissue. For instance, Elekta, a Swedish-based medical technology company, introduced Elekta Esprit in May 2022, an advanced radiosurgery system designed for high-precision stereotactic radiosurgery targeting brain tumors, vascular malformations, or functional disorders. Elekta Esprit provides clinicians with faster automated treatment planning, enabling more personalized and patient-friendly treatments with exceptional precision. This advanced system offers superior visualization, remote accessibility, and collaboration tools, allowing treatment teams to address even the most challenging targets with exceptional accuracy while ensuring a gentle, personalized approach to radiosurgery.

In December 2022, Eli Lilly and Company, a US-based pharmaceutical company, acquired Akouos, Inc. for approximately $487 million. This acquisition aligns with Lilly's strategic focus on expanding its genetic medicines portfolio and enhances its capabilities in adeno-associated viral gene therapies. Specifically, the acquisition strengthens Lilly's efforts to develop treatments for inner ear conditions, including sensorineural hearing loss. Akouos, Inc. is a US-based biotechnology company specializing in pioneering gene therapies for hearing-related disorders, making this acquisition an important step for Lilly in advancing its position in the emerging field of genetic treatments for hearing impairments.

Major companies operating in the acoustic neuroma market are Pfizer Inc, F. Hoffmann-La Roche AG, General Electric Company, Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GSK plc, Medtronic plc, Canon Medical Systems Corporation, Toshiba Medical Systems Corporation, Amgen Inc., Siemens Healthineers, Teva Pharmaceuticals Industries Ltd, Olympus Corporation, Shimadzu Corporation, Varian Medical Systems, Elekta AB, Cochlear Limited, Brainlab AG, Natus Medical Incorporated, CIVCO Medical Solutions, Monteris Medical, BrainScope Company Inc.

North America was the largest region in the acoustic neuroma market in 2024. The regions covered in the acoustic neuroma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the acoustic neuroma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acoustic neuroma market consists of revenues earned by entities by providing services such as neurosurgery, hearing tests, auditory rehabilitation, and counseling and support services for patients and families. The market value includes the value of related goods sold by the service provider or included within the service offering. The acoustic neuroma market also includes sales of hearing aids, surgical instruments, balance therapy equipment, and assistive listening devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acoustic Neuroma Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acoustic neuroma market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acoustic neuroma ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acoustic neuroma market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Unilateral Vestibular Schwannomas; Bilateral Vestibular Schwannomas
• 2) By Treatment Type: Drugs; Anticonvulsants; Radiation Therapy; Proton Therapy; Stereotactic Radiosurgery
• 3) Diagnosis Type: Magnetic Resonance Imaging (MRI); Computed Tomography Scan (CT-SCAN); Hearing Tests
• 4) By End User: Hospitals; Clinics; Surgical Centers
• Subsegments:
• 1) By Unilateral Vestibular Schwannomas: Small Unilateral Vestibular Schwannomas; Medium Unilateral Vestibular Schwannomas; Large Unilateral Vestibular Schwannomas; Malignant Unilateral Vestibular Schwannomas; Other Variants Of Unilateral Vestibular Schwannomas
• 2) By Bilateral Vestibular Schwannomas: Familial Bilateral Vestibular Schwannomas; Sporadic Bilateral Vestibular Schwannomas; Other Variants Of Bilateral Vestibular Schwannomas
• Companies Mentioned: Pfizer Inc; F. Hoffmann-La Roche AG; General Electric Company; Merck & Co. Inc.; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Acoustic Neuroma Market Characteristics

3. Acoustic Neuroma Market Trends And Strategies

4. Acoustic Neuroma Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Acoustic Neuroma Growth Analysis And Strategic Analysis Framework

• 5.1. Global Acoustic Neuroma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Acoustic Neuroma Market Growth Rate Analysis
• 5.4. Global Acoustic Neuroma Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Acoustic Neuroma Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Acoustic Neuroma Total Addressable Market (TAM)

6. Acoustic Neuroma Market Segmentation

• 6.1. Global Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Unilateral Vestibular Schwannomas
• Bilateral Vestibular Schwannomas
• 6.2. Global Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drugs
• Anticonvulsants
• Radiation Therapy
• Proton Therapy
• Stereotactic Radiosurgery
• 6.3. Global Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Magnetic Resonance Imaging (MRI)
• Computed Tomography Scan (CT-SCAN)
• Hearing Tests
• 6.4. Global Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Surgical Centers
• 6.5. Global Acoustic Neuroma Market, Sub-Segmentation Of Unilateral Vestibular Schwannomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Unilateral Vestibular Schwannomas
• Medium Unilateral Vestibular Schwannomas
• Large Unilateral Vestibular Schwannomas
• Malignant Unilateral Vestibular Schwannomas
• Other Variants Of Unilateral Vestibular Schwannomas
• 6.6. Global Acoustic Neuroma Market, Sub-Segmentation Of Bilateral Vestibular Schwannomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Familial Bilateral Vestibular Schwannomas
• Sporadic Bilateral Vestibular Schwannomas
• Other Variants Of Bilateral Vestibular Schwannomas

7. Acoustic Neuroma Market Regional And Country Analysis

• 7.1. Global Acoustic Neuroma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Acoustic Neuroma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Acoustic Neuroma Market

• 8.1. Asia-Pacific Acoustic Neuroma Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Acoustic Neuroma Market

• 9.1. China Acoustic Neuroma Market Overview
• 9.2. China Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Acoustic Neuroma Market

• 10.1. India Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Acoustic Neuroma Market

• 11.1. Japan Acoustic Neuroma Market Overview
• 11.2. Japan Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Acoustic Neuroma Market

• 12.1. Australia Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Acoustic Neuroma Market

• 13.1. Indonesia Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Acoustic Neuroma Market

• 14.1. South Korea Acoustic Neuroma Market Overview
• 14.2. South Korea Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Acoustic Neuroma Market

• 15.1. Western Europe Acoustic Neuroma Market Overview
• 15.2. Western Europe Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Acoustic Neuroma Market

• 16.1. UK Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Acoustic Neuroma Market

• 17.1. Germany Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Acoustic Neuroma Market

• 18.1. France Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Acoustic Neuroma Market

• 19.1. Italy Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Acoustic Neuroma Market

• 20.1. Spain Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Acoustic Neuroma Market

• 21.1. Eastern Europe Acoustic Neuroma Market Overview
• 21.2. Eastern Europe Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Acoustic Neuroma Market

• 22.1. Russia Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Acoustic Neuroma Market

• 23.1. North America Acoustic Neuroma Market Overview
• 23.2. North America Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Acoustic Neuroma Market

• 24.1. USA Acoustic Neuroma Market Overview
• 24.2. USA Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Acoustic Neuroma Market

• 25.1. Canada Acoustic Neuroma Market Overview
• 25.2. Canada Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Acoustic Neuroma Market

• 26.1. South America Acoustic Neuroma Market Overview
• 26.2. South America Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Acoustic Neuroma Market

• 27.1. Brazil Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Acoustic Neuroma Market

• 28.1. Middle East Acoustic Neuroma Market Overview
• 28.2. Middle East Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Acoustic Neuroma Market

• 29.1. Africa Acoustic Neuroma Market Overview
• 29.2. Africa Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Acoustic Neuroma Market Competitive Landscape And Company Profiles

• 30.1. Acoustic Neuroma Market Competitive Landscape
• 30.2. Acoustic Neuroma Market Company Profiles
  • 30.2.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. General Electric Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Acoustic Neuroma Market Other Major And Innovative Companies

• 31.1. AstraZeneca plc
• 31.2. Abbott Laboratories
• 31.3. Novartis AG
• 31.4. GSK plc
• 31.5. Medtronic plc
• 31.6. Canon Medical Systems Corporation
• 31.7. Toshiba Medical Systems Corporation
• 31.8. Amgen Inc.
• 31.9. Siemens Healthineers
• 31.10. Teva Pharmaceuticals Industries Ltd
• 31.11. Olympus Corporation
• 31.12. Shimadzu Corporation
• 31.13. Varian Medical Systems
• 31.14. Elekta AB
• 31.15. Cochlear Limited

32. Global Acoustic Neuroma Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acoustic Neuroma Market

34. Recent Developments In The Acoustic Neuroma Market

35. Acoustic Neuroma Market High Potential Countries, Segments and Strategies

• 35.1 Acoustic Neuroma Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Acoustic Neuroma Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Acoustic Neuroma Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료